scispace - formally typeset
A

Arda Shahinian

Researcher at Ontario Institute for Cancer Research

Publications -  42
Citations -  14909

Arda Shahinian is an academic researcher from Ontario Institute for Cancer Research. The author has contributed to research in topics: T cell & CD28. The author has an hindex of 31, co-authored 42 publications receiving 14465 citations. Previous affiliations of Arda Shahinian include University Health Network & Discovery Institute.

Papers
More filters
Journal ArticleDOI

Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4

TL;DR: Although CTLA-4-deficient T cells proliferated spontaneously and strongly when stimulated through the T cell receptor, they were sensitive to cell death induced by cross-linking of the Fas receptor and by gamma irradiation, and is vital for the control of lymphocyte homeostasis.
Journal ArticleDOI

Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection.

TL;DR: The TNFRp55 function renders mice resistant to lethal dosages of either lipopolysaccharides or S. aureus enterotoxin B, and the 55 kd TNFR plays a decisive role in the host's defense against microorganisms and their pathogenic factors.
Journal ArticleDOI

FADD: Essential for Embryo Development and Signaling from Some, But Not All, Inducers of Apoptosis

TL;DR: CD95, tumor necrosis factor receptor type 1 (TNFR-1), and death receptor 3 (DR3) did not induce apoptosis in FADD-deficient embryonic fibroblasts, whereas DR4, oncogenes E1A and c-myc, and chemotherapeutic agent adriamycin did.
Journal ArticleDOI

Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes

TL;DR: Examination of the role of CPP32 in apoptosis using mice, embryonic stem cells, and mouse embryonic fibroblasts deficient for the caspase indicates that CPP 32 is an essential component in apoptotic events that is remarkably system- and stimulus-dependent.